Table: Ono Pharm -6-MTH group results (IFRS)

ONO PHARMACEUTICAL

31/10/2019 03:00

Oct 31 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2019        Sep 30, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              149.01              144.40           290.00    
                   (+3.2 pct)          (+18.9 pct)      (+0.5 pct)  
  Operating           41.88               35.15            67.00    
                   (+19.1 pct)         (+31.2 pct)      (+8.0 pct)  
  Pretax              43.04               36.92            70.00    
                   (+16.6 pct)         (+30.0 pct)      (+7.5 pct)  
  Net                 32.82               28.85            53.00    
                   (+13.8 pct)         (+36.0 pct)      (+2.8 pct)  
  EPS Basic         64.58 yen           56.11 yen       103.09 yen  
  EPS Diluted       64.57 yen           56.10 yen                   
  Ann Div                               45.00 yen        45.00 yen  
  -Q2 Div           22.50 yen           22.50 yen                   
  -Q4 Div                               22.50 yen        22.50 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T